Literature DB >> 20378306

Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited.

Khalid A Azzam1, Mark Seeley, Elie Ghanem, Matthew S Austin, James J Purtill, Javad Parvizi.   

Abstract

Irrigation and debridement (I and D) is a procedure commonly used for the treatment of acute periprosthetic infection. This study retrospectively reviewed clinical records of patients with periprosthetic infection of the hip or knee who underwent I and D with retention of their prostheses between 1997 and 2005 at a single institution. One hundred four patients (44 males and 60 females) were identified. Mean age at time of initial debridement was 65 years. Average follow-up was 5.7 years. Treatment failure was defined as the need for resection arthroplasty or recurrent microbiologically proven infection. According to these criteria, I and D was successful in 46 patients (44%). Patients with staphylococcal infection, elevated American Society of Anesthesiologists score, and purulence around the prosthesis were more likely to fail. The high failure rate of this procedure implies that it should be preferably limited to select healthy patients with low virulence organisms and equivocal intraoperative findings.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378306     DOI: 10.1016/j.arth.2010.01.104

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  70 in total

1.  [Hip joint infections - Results of a questionnaire among 28 university orthopedic departments].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

2.  The use of a multiplanar, multi-axis external fixator to achieve knee arthrodesis in a worst case scenario: a case series.

Authors:  Dima Raskolnikov; James D Slover; Kenneth A Egol
Journal:  Iowa Orthop J       Date:  2013

3.  Failure of irrigation and débridement for early postoperative periprosthetic infection.

Authors:  Thomas K Fehring; Susan M Odum; Keith R Berend; William A Jiranek; Javad Parvizi; Kevin J Bozic; Craig J Della Valle; Terence J Gioe
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

4.  Bacteria detected after instrumentation surgery for pyogenic vertebral osteomyelitis in a canine model.

Authors:  Wei-Hua Chen; Yi-Jun Kang; Li-Yang Dai; Bing Wang; Chang Lu; Jing Li; Guo-Hua Lü
Journal:  Eur Spine J       Date:  2013-10-12       Impact factor: 3.134

5.  What is the Long-term Economic Societal Effect of Periprosthetic Infections After THA? A Markov Analysis.

Authors:  Thomas J Parisi; Joseph F Konopka; Hany S Bedair
Journal:  Clin Orthop Relat Res       Date:  2017-04-07       Impact factor: 4.176

6.  Culture-negative periprosthetic joint infection does not preclude infection control.

Authors:  Ronald Huang; Chi-Chien Hu; Bahar Adeli; Javad Mortazavi; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

7.  Irrigation and debridement for periprosthetic infections of the hip and factors determining outcome.

Authors:  Georgios K Triantafyllopoulos; Lazaros A Poultsides; Vasileios I Sakellariou; Wei Zhang; Peter K Sculco; Yan Ma; Thomas P Sculco
Journal:  Int Orthop       Date:  2015-03-31       Impact factor: 3.075

Review 8.  Treatment of acute periprosthetic infections with prosthesis retention: Review of current concepts.

Authors:  Jesse Wp Kuiper; Robin Tjeenk Willink; Dirk Jan F Moojen; Michel Pj van den Bekerom; Sascha Colen
Journal:  World J Orthop       Date:  2014-11-18

Review 9.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

10.  Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus.

Authors:  Claudio Diaz-Ledezma; Carlos A Higuera; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2013-02-26       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.